These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2850197

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intracerebroventricular administration of kappa-agonists induces convulsions in mice.
    Bansinath M, Ramabadran K, Turndorf H, Shukla VK.
    Brain Res Bull; 1991 Jul; 27(1):75-9. PubMed ID: 1657321
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW, Folk JE, Linsenmayer DC, Rice KC, Negus SS.
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Facilitation of memory retrieval by pretest morphine mediated by mu but not delta and kappa opioid receptors.
    Shiigi Y, Takahashi M, Kaneto H.
    Psychopharmacology (Berl); 1990 Dec; 102(3):329-32. PubMed ID: 2174567
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands.
    Shippenberg TS, Herz A.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1101-6. PubMed ID: 1848627
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET.
    Alcohol Drug Res; 1991 Mar; 6(5):327-39. PubMed ID: 3011025
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD, Eisenstein TK, Geller EB, Adler MW, Rogers TJ.
    Proc Natl Acad Sci U S A; 1991 Jan 15; 88(2):360-4. PubMed ID: 1846441
    [Abstract] [Full Text] [Related]

  • 20. Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
    Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ.
    Psychopharmacology (Berl); 2004 Apr 15; 173(1-2):146-52. PubMed ID: 14712342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.